ArticleFrontiers in oncology2022

Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia.

Fabio Giglio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.